WO2001011333B1 - Apparatus for real-time measurement of cellular response - Google Patents

Apparatus for real-time measurement of cellular response

Info

Publication number
WO2001011333B1
WO2001011333B1 PCT/US2000/021339 US0021339W WO0111333B1 WO 2001011333 B1 WO2001011333 B1 WO 2001011333B1 US 0021339 W US0021339 W US 0021339W WO 0111333 B1 WO0111333 B1 WO 0111333B1
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
test
cellular response
cellular
detection zone
Prior art date
Application number
PCT/US2000/021339
Other languages
French (fr)
Other versions
WO2001011333A2 (en
WO2001011333A3 (en
Inventor
John Ransom
Ilya Okun
Alex Okun
Original Assignee
Axiom Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axiom Biotechnologies Inc filed Critical Axiom Biotechnologies Inc
Priority to AU68937/00A priority Critical patent/AU6893700A/en
Priority to EP00957298A priority patent/EP1204864A2/en
Priority to JP2001515940A priority patent/JP2003506098A/en
Publication of WO2001011333A2 publication Critical patent/WO2001011333A2/en
Publication of WO2001011333A3 publication Critical patent/WO2001011333A3/en
Publication of WO2001011333B1 publication Critical patent/WO2001011333B1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G01N15/1404—Fluid conditioning in flow cytometers, e.g. flow cells; Supply; Control of flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G01N33/5079—Mitochondria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302—Apparatus specially adapted for immunological test procedures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive

Abstract

An apparatus and method for real-time measurement of a cellular response of a test compound or series of test compounds (303) on a flowing suspension of cells (349), in which a homogeneous suspension of each member of a series of cell types (349) is combined with a concentration of a test compound (303), directed through a detection zone (355), and a cellular response of the living cells is measured in real time as the cells in the test mixture are flowing through the detection zone (355). The apparatus may be used in automated screening of libraries of compounds, and is capable of real-time variation of concentrations of test and standard compounds and generation of dose/response profiles within a short time span.

Claims

AMENDED CLAIMS[received by the International Bureau on 14 April 2001 (14 04 01), original claims 1 , 5. 6, 9, 16. 22, 26, 30, 40-42, 50, 51 and 60 amended. new claims 66-84 added, remaining claims unchanged (9 pages)]
1. A method for identifying compounds which produce a cellular response comprising:
(a) using an automated and computer controlled apparatus to sequentially combine a each of a plurality of cell suspensions with one or more test compounds to sequentially form each of a plurality of test mixtures;
(b) sequentially directing each of said plurality of test mixtures through a detection zone, the detection zone being capable of detecting a plurality of cellular responses simultaneously; and
(c) simultaneously measuring a plurality of cellular responses to the one or more test compounds in said suspended cells as each of said plurality of test mixtures are flowing through said detection zone.
2. The method of Claim 1 , wherein said plurality of cellular responses includes a cellular response selected from the group consisting of activation or inhibition of a receptor mediated response, activation or inhibition of an ion channel, activation or inhibition of a non selective pore, activation or inhibition of a second messenger pathway at a point downstream of a receptor or channel, activation or inhibition of apoptosis, activation or inhibition of cellular necrosis, and cellular toxicitγ.
3. The method of Claim 1, wherein said plurality of cellular responses are measured by contacting said cells with one or more response indicating reagents which generate signals indicative of particular cellular responses.
4. The method of Claim 3, wherein said signal generated by said response indicating reagents is fluorescence.
5. The method of Claim 1 , wherein said step of sequentially directing each of said plurality of test mixtures through a detection zone comprises directing each of said plurality of test mixtures through a detection zone which is capable of detecting said cellular responses in individual cells.
6 The method of Claim 1 wherein said step of sequentially directing each of said plurality of test mixtures through a detection zone comprises directing each of said plurality of test mixtures through a flow cytometer.
7 The method of Claim 1 , wherein the step of simultaneously measuring a plurality of cellular responses comprises measuring said plurality of cellular responses in said suspended cells as a slug is flowing through said detection zone.
8 The method of Claim 1 , wherein each of said plurality of cell suspensions comprises more than one type of cell.
9 A method for identifying compounds which produce a cellular response comprising:
(a) using an automated and computer controlled apparatus to sequentially combine each of a plurality of cell suspensions with one or more test compounds to form each of a plurality of test mixtures;
(b) sequentially directing each of said plurality of test mixtures through a detection zone, said detection zone being capable of detecting cellular responses in individual cells; and
- 78 -
10. The method of Claim 9, wherein said one or more cellular responses is selected from the group consisting of activation or inhibition of a receptor mediated response, activation or inhibition of an ion channel, activation or inhibition of a non-selective pore, activation or inhibition of a second messenger pathway at a point downstream of a receptor or channel, activation or inhibition of apoptosis, and activation or inhibition of cellular necrosis, and cellular toxicity.
1 1. The method of Claim 9, wherein said one or more cellular responses is measured by contacting said cells with one or more response indicating reagents which generate signals indicative of particular cellular responses.
12. The method of Claim 1 1, wherein said signal generated by said response indicating reagents is fluorescence
13 The method of Claim 9 wherein said step of directing each of said plurality of test mixtures through a detection zone comprises directing each of said plurality of test mixtures through a flow cytometer.
14 The method of Claim 9, wherein each of said plurality of cell suspensions comprises more than one type of cell.
15. The method of Claim 9, wherein the step of simultaneously measuring a plurality of cellular responses comprises measuring said plurality of cellular responses in said suspended cells as a slug is flowing through said detection zone.
16. A method of determining whether a sample contains one or more molecules comprising: using an automated and computer controlled apparatus to sequentially combine one or more agents capable of binding one or more molecules with each of a plurality of samples to form a plurality of test mixtures; sequentially directing each of said plurality of test mixtures through a detection zone; and determining whether said one or more agents are bound to said one or more molecules as each of said test mixtures are flowing through said detection zone.
17 The method of Claim 16, wherein said one or more agents are fixed to a solid support.
18. The method of Claim 17, wherein a plurality of agents capable of binding a plurality of molecules are fixed to uniquely identifiable solid supports.
19. The method of Claim 18 wherein said determining step comprises detecting a signal from an individual solid support wherein said signal indicates that said agent on said solid support has bound to said molecule.
20. The method of Claim 16, wherein said one or more agents are selected from the group consisting of antibodies nucleic acids, polypeptides, enzymatic substrates, and receptors.
21. The method of Claim 16, wherein said one or more molecules are selected from the group consisting of polypeptides, nucleic acids, receptor ligands, enzymatic agonists and enzymatic antagonists.
22. A method of determining whether a sample contains one or more polypeptides comprising: attaching one or more antibodies which specifically bind said one or more polypeptides to solid supports;
- 79 - using an automated and computer controlled apparatus to sequentially combine said one or more antibodies attached to solid supports with samples to form a plurality of test mixtures; sequentially directing each of said plurality of test mixtures through a detection zone; and determining whether said one or more antibodies are bound to said one or more polypeptides as each of test mixtures are flowing through said detection zone.
23. The method of Claim 22, wherein a plurality of antibodies which specifically bind to a plurality of polypeptides are fixed to uniquely identifiable solid supports.
24 The method of Claim 23 wherein said determining step comprises detecting a signal from an individual solid support wherein said signal indicates that said antibodies have bound to said molecules.
25. The method of Claim 24, wherein said signal is generated by detectably labeled secondary antibodies which bind said molecules.
26. A method of determining whether a sample contains one or more nucleic acids comprising: attaching one or more nucleic acid probes which specifically bind said nucleic acids to solid supports, using an automated and computer controlled apparatus to sequentially combine said one or more probes attached to said solid supports with samples to form a plurality test mixtures; sequentially directing each of said plurality of test mixtures through a detection zone; and determining whether said one or more probes are bound to said one or more nucleic acids as each of said test mixtures are flowing through said detection zone.
27. The method of Claim 26, wherein a plurality of nucleic acid probes are fixed to uniquely addressable solid supports.
28. The method of Claim 27, wherein said determining step comprises detecting a signal from an individual solid support wherein said signal indicates that said probes have bound to said nucleic acids
29 The method of Claim 28, wherein said signal is generated by detectable nucleic acid probes which bind said nucleic acids.
30. A method of determining whether a sample contains one or more single nucleotide polymorphisms comprising: performing an extension reaction on a each of a plurality of nucleic acid samples using one or more nucleic acid primers for each of said plurality of nucleic acid samples, said one or more nucleic acid primers having a 3' end immediately adjacent to the polymorphic base of one or more single nucleotide polymorphisms, thereby incorporating one base into said nucleic acid primers; attaching the extended primers to solid supports; sequentially directing said solid supports having primers attached thereto for each of said plurality of nucleic acid samples through a detection zone in an apparatus; and determining the identities of the bases incorporated in said extension reaction.
- 80 -
35. The method of Claim 1 , wherein one or more standard compounds and said one or more test compounds are simultaneously mixed with each of said cell suspensions, and said measuring step detects whether said one or more test compounds alter a known effect of said one or more standard compounds.
31. The method of Claim 30, wherein a plurality of primers are fixed to uniquely identifiable solid supports.
32. The method of Claim 31 , wherein said determining step comprises detecting a signal from an individual solid support wherein said signal is indicative of the identity of the polymorphic base in a SIMP.
33. The method of Claim 32, wherein said signal is generated by detectably labeled nucleotides incorporated in said extension reaction.
34. The method of Claim 1 , further comprising the steps of:
(d) combining a suspension of said cells with one or more standard compounds having a known effect on said cellular response of said cells to form standard mixtures;
(e) directing the standard mixtures through the detection zone; and
(f) measuring the cellular response of said cells to said one or more standard compounds
35. The method of Claim 34, wherein said one or more standard compounds and said one or more test compounds are simultaneously mixed with said cells in said combining steps, and said measuring step detects said known effect or an alteration of said known effect.
36. The method of Claim 35, wherein said one or more standard compounds is an antagonist of said cellular response
37. The method of Claim 35, wherein said one or more standard compounds is an agonist of said cellular response.
38. The method of Claim 35, wherein said cell suspensions comprise more than one cell type.
39. The method of Claim 35, wherein the step of directing said test mixtures through a detection zone comprises directing said test mixtures through a flow cytometer.
40. A method of obtaining cells having a desired phenotype or cellular response profile comprising the steps of:
(a) using an automated and computer controlled apparatus to sequentially combine a each of a plurality of cell suspensions with one or more compounds which produce a cellular response to form a plurality of test mixtures;
(b) sequentially directing each of said plurality of test mixtures through a detection zone, said detection zone being capable of detecting a plurality of cellular parameters simultaneously;
(c) simultaneously measuring a plurality of cellular parameters in said suspended cells as each of said plurality of test mixtures are flowing through said detection zone; and
(d) delivering cells having a desired phenotype or cellular response profile into a receptacle.
41. A method of obtaining cells having a desired phenotype or cellular response profile comprising the steps of:
- 81 - (a) using an automated and computer controlled apparatus to sequentially combine a each of a plurality of cell suspensions with one or more compounds which produce a cellular response to form a plurality of test mixtures,
(b) sequentially directing each of said plurality of test mixtures through a detection zone, said detection zone being capable of detecting cellular responses in individual cells;
(c) simultaneously measuring a plurality of cellular parameters in said suspended cells as each of said plurality of test mixtures are flowing through said detection zone; and
(d) delivering cells having a desired phenotype or cellular response profile into a receptacle.
42 An apparatus comprising: an automated test compound source capable of sequentially providing each of a plurality of test compounds; an automated test substrate source capable of sequentially providing each of a plurality of test substrates, a mixing chamber in fluid communication with said test compound source and said test substrate source, wherein said mixing chamber is adapted to combine a test compound received from said test compound source with a test substrate received from said test substrate source to generate a mixture, and a detector in fluid communication with said mixing chamber, said detector being capable of simultaneously detecting a plurality of interactions between said test compounds and said test substrates while said mixture is passing through said detector.
43. The apparatus of Claim 42, wherein: said test compound source comprises one or more sample inputs for sequentially providing each of a plurality of samples, each of said samples comprising one or more test compounds to be evaluated for the ability to produce a cellular response or a solution to be evaluated for the presence of molecules, said test substrate source comprises one or more cell or particle inputs for sequentially providing a each of a plurality of cell suspensions or particles; said mixing chamber receives the samples from said test compound source, receives the cell suspensions or particles from the cell or particle input and mixes each sample with the cell suspension or particles; and said detector is capable of detecting a plurality of signals simultaneously such that said detector can simultaneously measure a plurality of cellular responses in the suspended cells or simultaneously determine whether a plurality of molecules are present in said samples.
44. The apparatus of Claim 43 wherein said detector detects a signal from a single cell in said cell suspension or from a single particle.
45. The apparatus of Claim 43 wherein said detector is a flow cytometer.
- 82 -
46 The apparatus of Claim 43, further comprising a coupler disposed between said mixing zone and said detector
47. The apparatus of Claim 46, wherein said coupler delivers slugs comprising said samples and said cell suspension or particles to said detector.
48. The apparatus of Claim 47, wherein said coupler delivers substantially undiluted slugs to said detector.
49. The apparatus of Claim 43, wherein said detector delivers cells having a desired phenotype or cellular response to a receptacle.
50. The apparatus of Claim 43 wherein said one or more sampie inputs comprise an automated robotic sampler capable of sequentially selecting each of a plurality of specified test compounds from a library of test compounds.
51. The apparatus of Claim 50 further comprising: a controller, coupled to said one or more sample inputs, for controlling the operation of the automated robotic sampler; and a computer, coupled to the controller, for sending command signals to the controller in accordance with a software program implemented by the computer, thereby controlling the selection and retrieval of test compounds by said one or more sample inputs from said test compound library.
52. The apparatus of Claim 51 further comprising a gradient pump having an input and an output, coupled to said sample input, for adjusting the concentration level of said test compound transferred to said mixing zone from said sample input, wherein: said sample input comprises: a first intake nozzle for receiving each of the said specified test compounds; a second intake nozzle for receiving a buffer solution; and wherein said gradient pump is coupled to the first and second intake nozzles and receives specified concentrations of each of the specified test compounds by adjusting the amount of test compound and buffer solution received by the first and second intake nozzles, respectively, wherein the buffer solution is a diluting agent of the test compound.
53. The apparatus of Claim 52 further comprising a second pump, coupled to an input of said mixing zone, for pumping said suspension of cells or said particles from said cell or particle input into the mixing zone.
54. The apparatus of Claim 53 further comprising a reaction developing line, having an input coupled to an output of said mixing zone and an output in fluid communication with said detector wherein said reaction developing line provides a reaction time delay for a mixture received from the mixing zone.
55. The apparatus of Claim 54 further comprising: a pump, coupled to the output of said detector, for providing negative pressure to the apparatus; a proportionating valve, coupled to said sample input, for adjusting the concentration level of said test compound transferred to said mixing zone from said one or more sample inputs, wherein said one or more sample inputs further comprise: a first intake nozzle for receiving each of said specified test compounds; a second intake nozzle for receiving a buffer solution; and the proportionating valve receives specified concentrations of each of the specified test compounds by adjusting the amount of test compound and buffer solution received by the first and second intake nozzles, respectively, wherein the buffer solution is a diluting agent of the test compound.
56. The apparatus of Claim 43 further comprising a plurality of cell suspension reservoirs.
57. The apparatus of Claim 43 further comprising a standard compound sampler, coupled to said mixing zone, for providing one or more standard compounds having a known effect on said cellular response of said suspended cells or a known interaction with said particles, wherein said mixing zone receives said one or more standard compounds from the standard compound sampler and mixes said one or more standard compounds with the suspended cells or particles and said detector measures the cellular response of the suspended cells to said one or more standard compounds or the interaction between said one or more standard compounds and said particles.
58. The apparatus of Claim 57 wherein said mixing zone simultaneously mixes said sample and said one or more standard compounds with said suspended cells or said particles and said detector detects said known effect or an alteration of said known effect on the cellular responses of said suspended cells or said known interaction between said standard compound and said particles or an alteration of said known interaction between said standard compound and said particles.
59. The apparatus of Claim 58 wherein said standard compound sampler is an automated robotic sampler capable of selecting a specified standard compound from a library of standard compounds.
60 An apparatus comprising- one or more automated sample inputs for sequentially providing each of a plurality of samples, said each of said samples comprising one or more test compounds to be evaluated for the ability to produce a cellular response or a solution to be evaluated for the presence of molecules; one or more automated cell or particle inputs for sequentially providing each of a plurality of cell suspensions or particles, a mixing zone, coupled to said sample input, for receiving the samples, receiving the cell suspension or particles from the cell or particle input and mixing each sample with the cell suspensions or particles; and a detector which detects one or more signals from a single cell or particle, said detector being coupled to the mixing zone and being capable of measuring one or more cellular responses in the suspended cells or determining whether one or more molecules are present in said samples.
61 The apparatus of Claim 60, further comprising a coupler disposed between said mixing zone and said detector
- 84 -
62. The apparatus of Claim 61 , wherein said coupler delivers slugs comprising said samples and said cell suspension or particles to said detector.
63. The apparatus of Claim 62, wherein said coupler delivers substantially undiluted slugs to said detector.
64 The apparatus of Claim 60 further comprising an input system for inputting solutions into said mixing zone.
65. The apparatus of Claim 60, wherein said detector delivers cells having a desired phenotype or cellular response to a receptacle.
66. The apparatus of Claim 42, wherein said test compound source is capable of providing said test compounds at a single concentration or over a range of concentrations.
67. The apparatus of Claim 42, further comprising a known compound source capable of sequentially providing each of a plurality of compounds which produce a known cellular response, said known compound source being in fluid communication with said mixing chamber such that said mixing chamber can combine a test compound, a compound which produces a known cellular response, and a cell suspension.
68. The apparatus of Claim 67, wherein said known compound source is capable of providing the compounds which produce a known cellular response at a single concentration or over a range of concentrations.
69. The apparatus of Claim 60, wherein said one or more sample inputs is capable of providing said test compounds at a single concentration or over a range of concentrations.
70. The apparatus of Claim 60, further comprising a known compound source capable of sequentially providing each of a plurality of compounds which produce a known cellular response, said known compound source being in fluid communication with said mixing zone such that said mixing zone can combine a test compound, a compound which produces a known cellular response, and a cell suspension.
71. The apparatus of Claim 70, wherein said known compound source is capable of providing the compounds which produce a known cellular response at a single concentration or over a range of concentrations.
72. The method of Claim 1, wherein a range of concentrations of said test compounds is combined with said cell suspensions.
73. The method of Claim 1 , further comprising combining one or more compounds which produce a known cellular response with said plurality of cell suspensions and said test compounds.
74. The method of Claim 73, wherein a range of concentrations of said one or more compounds which produce a known cellular response is combined with said plurality of cell suspensions and said test compounds.
75. The method of Claim 9, wherein a range of concentrations of said test compounds is combined with said cell suspensions.
76. The method of Claim 9, further comprising combining one or more compounds which produce a known cellular response with said plurality of cell suspensions and said test compounds.
77. The method of Claim 76, wherein a range of concentrations of said one or more compounds which produce a known cellular response is combined with said plurality of cell suspensions and said test compounds.
- 85 -
78. The method of Claim 1 , wherein a range of concentrations of said agents capable of binding said molecules is combined with said samples.
79. The method of Claim 40, wherein a range of concentrations of said compounds is combined with said cell suspensions.
80. The method of Claim 40, further comprising combining one or more compounds which produce a known cellular response with said plurality of cell suspensions and said compounds.
81. The method of Claim 80, wherein a range of concentrations of said one or more compounds which produce a known cellular response is combined with said plurality of cell suspensions and said compounds.
82. The method of Claim 41, wherein a range of concentrations of said compounds is combined with said cell suspensions.
83. The method of Claim 41 , further comprising combining one or more compounds which produce a known cellular response with said plurality of cell suspensions and said compounds.
84. The method of Claim 83, wherein a range of concentrations of said one or more compounds which produce a known cellular response is combined with said plurality of celi suspensions and said compounds.
- 86 -
PCT/US2000/021339 1999-08-05 2000-08-04 Apparatus for real-time measurement of cellular response WO2001011333A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU68937/00A AU6893700A (en) 1999-08-05 2000-08-04 Apparatus and method for real-time measurement of cellular response
EP00957298A EP1204864A2 (en) 1999-08-05 2000-08-04 Apparatus for real-time measurement of cellular response
JP2001515940A JP2003506098A (en) 1999-08-05 2000-08-04 Apparatus and method for measuring cell response in real time

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/370,786 US6280967B1 (en) 1996-08-02 1999-08-05 Cell flow apparatus and method for real-time of cellular responses
US09/370,786 1999-08-05

Publications (3)

Publication Number Publication Date
WO2001011333A2 WO2001011333A2 (en) 2001-02-15
WO2001011333A3 WO2001011333A3 (en) 2001-08-30
WO2001011333B1 true WO2001011333B1 (en) 2001-09-27

Family

ID=23461174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/021339 WO2001011333A2 (en) 1999-08-05 2000-08-04 Apparatus for real-time measurement of cellular response

Country Status (5)

Country Link
US (2) US6280967B1 (en)
EP (1) EP1204864A2 (en)
JP (1) JP2003506098A (en)
AU (1) AU6893700A (en)
WO (1) WO2001011333A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815664B2 (en) 2001-04-27 2004-11-09 Genoptix, Inc. Method for separation of particles
US6833542B2 (en) 2000-11-13 2004-12-21 Genoptix, Inc. Method for sorting particles

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048734A (en) 1995-09-15 2000-04-11 The Regents Of The University Of Michigan Thermal microvalves in a fluid flow method
US5942443A (en) * 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
US6558916B2 (en) * 1996-08-02 2003-05-06 Axiom Biotechnologies, Inc. Cell flow apparatus and method for real-time measurements of patient cellular responses
US6589729B2 (en) 2000-02-04 2003-07-08 Caliper Technologies Corp. Methods, devices, and systems for monitoring time dependent reactions
AU785424B2 (en) * 2000-07-26 2007-05-17 Regents Of The University Of California, The Manipulation of live cells and inorganic objects with optical micro beam arrays
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
US6893851B2 (en) 2000-11-08 2005-05-17 Surface Logix, Inc. Method for arraying biomolecules and for monitoring cell motility in real-time
US7033819B2 (en) 2000-11-08 2006-04-25 Surface Logix, Inc. System for monitoring cell motility in real-time
US6844184B2 (en) * 2000-11-08 2005-01-18 Surface Logix, Inc. Device for arraying biomolecules and for monitoring cell motility in real-time
US7374906B2 (en) 2000-11-08 2008-05-20 Surface Logix, Inc. Biological assays using gradients formed in microfluidic systems
US6864065B2 (en) * 2000-11-08 2005-03-08 Surface Logix, Inc. Assays for monitoring cell motility in real-time
US7326563B2 (en) * 2000-11-08 2008-02-05 Surface Logix, Inc. Device and method for monitoring leukocyte migration
US7033821B2 (en) * 2000-11-08 2006-04-25 Surface Logix, Inc. Device for monitoring cell motility in real-time
US20020160470A1 (en) * 2000-11-13 2002-10-31 Genoptix Methods and apparatus for generating and utilizing linear moving optical gradients
US6784420B2 (en) 2000-11-13 2004-08-31 Genoptix, Inc. Method of separating particles using an optical gradient
US20020121443A1 (en) * 2000-11-13 2002-09-05 Genoptix Methods for the combined electrical and optical identification, characterization and/or sorting of particles
US6936811B2 (en) * 2000-11-13 2005-08-30 Genoptix, Inc. Method for separating micro-particles
US20020123112A1 (en) * 2000-11-13 2002-09-05 Genoptix Methods for increasing detection sensitivity in optical dielectric sorting systems
US6744038B2 (en) 2000-11-13 2004-06-01 Genoptix, Inc. Methods of separating particles using an optical gradient
US6778724B2 (en) 2000-11-28 2004-08-17 The Regents Of The University Of California Optical switching and sorting of biological samples and microparticles transported in a micro-fluidic device, including integrated bio-chip devices
US6692700B2 (en) 2001-02-14 2004-02-17 Handylab, Inc. Heat-reduction methods and systems related to microfluidic devices
US7323140B2 (en) 2001-03-28 2008-01-29 Handylab, Inc. Moving microdroplets in a microfluidic device
US8895311B1 (en) 2001-03-28 2014-11-25 Handylab, Inc. Methods and systems for control of general purpose microfluidic devices
US7829025B2 (en) 2001-03-28 2010-11-09 Venture Lending & Leasing Iv, Inc. Systems and methods for thermal actuation of microfluidic devices
US6852287B2 (en) 2001-09-12 2005-02-08 Handylab, Inc. Microfluidic devices having a reduced number of input and output connections
US7010391B2 (en) 2001-03-28 2006-03-07 Handylab, Inc. Methods and systems for control of microfluidic devices
US20040009540A1 (en) * 2001-04-27 2004-01-15 Genoptix, Inc Detection and evaluation of cancer cells using optophoretic analysis
US20030194755A1 (en) * 2001-04-27 2003-10-16 Genoptix, Inc. Early detection of apoptotic events and apoptosis using optophoretic analysis
US20020189947A1 (en) * 2001-06-13 2002-12-19 Eksigent Technologies Llp Electroosmotic flow controller
US7465382B2 (en) * 2001-06-13 2008-12-16 Eksigent Technologies Llc Precision flow control system
US20030082584A1 (en) * 2001-06-29 2003-05-01 Liang Shi Enzymatic ligation-based identification of transcript expression
US20030170695A1 (en) * 2001-06-29 2003-09-11 Liang Shi Enzymatic ligation-based identification of nucleotide sequences
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7695926B2 (en) 2001-07-10 2010-04-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting receptor-ligand interactions in single cells
US7381535B2 (en) * 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
AU2002365421A1 (en) 2001-07-10 2003-09-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US20050203578A1 (en) * 2001-08-15 2005-09-15 Weiner Michael L. Process and apparatus for treating biological organisms
US7244611B2 (en) * 2001-10-23 2007-07-17 Nikon Research Corporation Of America Methods and devices for hybridization and binding assays using thermophoresis
US20060134683A1 (en) * 2001-10-23 2006-06-22 Michael Sogard Methods and devices for hybridization and binding assays using thermophoresis
AU2003205132A1 (en) * 2002-02-12 2003-09-04 Celectricon AB Systems and methods for rapidly changing the solution environment around sensors
AU2003220254B2 (en) 2002-03-13 2008-09-18 Syngenta Participations, Ag. Nucleic acid detection method
US7157274B2 (en) * 2002-06-24 2007-01-02 Cytonome, Inc. Method and apparatus for sorting particles
US6808075B2 (en) 2002-04-17 2004-10-26 Cytonome, Inc. Method and apparatus for sorting particles
US20070065808A1 (en) * 2002-04-17 2007-03-22 Cytonome, Inc. Method and apparatus for sorting particles
US9943847B2 (en) 2002-04-17 2018-04-17 Cytonome/St, Llc Microfluidic system including a bubble valve for regulating fluid flow through a microchannel
US6976590B2 (en) 2002-06-24 2005-12-20 Cytonome, Inc. Method and apparatus for sorting particles
US20040033539A1 (en) * 2002-05-01 2004-02-19 Genoptix, Inc Method of using optical interrogation to determine a biological property of a cell or population of cells
US20030211461A1 (en) * 2002-05-01 2003-11-13 Genoptix, Inc Optophoretic detection of durgs exhibiting inhibitory effect on Bcr-Abl positive tumor cells
WO2004018690A1 (en) * 2002-08-21 2004-03-04 Cellectricon Ab System and method for obtaining and maintaining high resistance seals in patch clamp recordings
US20040053209A1 (en) * 2002-09-12 2004-03-18 Genoptix, Inc Detection and evaluation of topoisomerase inhibitors using optophoretic analysis
ES2375724T3 (en) 2002-09-27 2012-03-05 The General Hospital Corporation MICROFLUDE DEVICE FOR SEPERATION OF CELLS AND ITS USES.
TW590982B (en) * 2002-09-27 2004-06-11 Agnitio Science & Technology I Micro-fluid driving device
US20040067167A1 (en) * 2002-10-08 2004-04-08 Genoptix, Inc. Methods and apparatus for optophoretic diagnosis of cells and particles
AU2003278461A1 (en) 2002-10-16 2004-05-04 Cellectricon Ab Nanoelectrodes and nanotips for recording transmembrane currents in a plurality of cells
US20040121307A1 (en) * 2002-12-19 2004-06-24 Genoptix, Inc Early detection of cellular differentiation using optophoresis
US20040121474A1 (en) * 2002-12-19 2004-06-24 Genoptix, Inc Detection and evaluation of chemically-mediated and ligand-mediated t-cell activation using optophoretic analysis
US7820030B2 (en) 2003-04-16 2010-10-26 Handylab, Inc. System and method for electrochemical detection of biological compounds
US20050021241A1 (en) * 2003-05-07 2005-01-27 Ballesteros Juan A. Gain of function sorting for drug discovery and development
US20050009060A1 (en) * 2003-05-07 2005-01-13 Andrew Beernink Multiplexed multitarget screening method
US7731906B2 (en) 2003-07-31 2010-06-08 Handylab, Inc. Processing particle-containing samples
AU2004269406B2 (en) 2003-08-28 2010-12-16 Progenity, Inc. Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
JP4454998B2 (en) * 2003-09-29 2010-04-21 株式会社ニコン Cell observation apparatus and cell observation method
AU2005218769B8 (en) * 2004-02-27 2012-04-12 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Pharmacodynamic assays using flow cytometry
AU2005241080B2 (en) 2004-05-03 2011-08-11 Handylab, Inc. Processing polynucleotide-containing samples
US8852862B2 (en) 2004-05-03 2014-10-07 Handylab, Inc. Method for processing polynucleotide-containing samples
US20050249642A1 (en) * 2004-05-07 2005-11-10 Novasite Pharmaceuticals, Inc. Sample analysis system employing direct sample mixing and injection
US7858040B2 (en) * 2004-05-07 2010-12-28 Saryna Biotechnologies Llc Direct mixing and injection for high throughput fluidic systems
US9260693B2 (en) 2004-12-03 2016-02-16 Cytonome/St, Llc Actuation of parallel microfluidic arrays
US20070009923A1 (en) * 2005-01-24 2007-01-11 Massachusetts Institute Of Technology Use of bayesian networks for modeling cell signaling systems
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
EP1989322A2 (en) * 2006-02-08 2008-11-12 Analytical Nano Technologies Limited Monitoring enzyme mixtures
US20070184510A1 (en) * 2006-02-08 2007-08-09 Frederick Rowell Method and apparatus for monitoring enzyme mixtures
US8883490B2 (en) 2006-03-24 2014-11-11 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US11806718B2 (en) 2006-03-24 2023-11-07 Handylab, Inc. Fluorescence detector for microfluidic diagnostic system
US7998708B2 (en) 2006-03-24 2011-08-16 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
US10900066B2 (en) 2006-03-24 2021-01-26 Handylab, Inc. Microfluidic system for amplifying and detecting polynucleotides in parallel
JP5415253B2 (en) 2006-03-24 2014-02-12 ハンディラブ・インコーポレーテッド Integrated system for processing microfluidic samples and methods of use thereof
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
US20090087925A1 (en) * 2007-10-01 2009-04-02 Zyomyx, Inc. Devices and methods for analysis of samples with depletion of analyte content
WO2008156491A2 (en) * 2006-09-29 2008-12-24 Zyomyx, Inc. Devices and methods for analysis of samples with depletion of analyte content
WO2008061165A2 (en) 2006-11-14 2008-05-22 Handylab, Inc. Microfluidic cartridge and method of making same
WO2008142689A1 (en) * 2007-05-21 2008-11-27 Bio-Rad Laboratories Inc. Optical resonance analysis using a multi-angle source of illumination
US8182763B2 (en) 2007-07-13 2012-05-22 Handylab, Inc. Rack for sample tubes and reagent holders
US8105783B2 (en) 2007-07-13 2012-01-31 Handylab, Inc. Microfluidic cartridge
US8287820B2 (en) 2007-07-13 2012-10-16 Handylab, Inc. Automated pipetting apparatus having a combined liquid pump and pipette head system
US9186677B2 (en) 2007-07-13 2015-11-17 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
US20090136385A1 (en) 2007-07-13 2009-05-28 Handylab, Inc. Reagent Tube
WO2009012185A1 (en) 2007-07-13 2009-01-22 Handylab, Inc. Polynucleotide capture materials, and methods of using same
US9618139B2 (en) 2007-07-13 2017-04-11 Handylab, Inc. Integrated heater and magnetic separator
US8133671B2 (en) 2007-07-13 2012-03-13 Handylab, Inc. Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
USD621060S1 (en) 2008-07-14 2010-08-03 Handylab, Inc. Microfluidic cartridge
WO2009134944A2 (en) * 2008-04-29 2009-11-05 Nodality, Inc. Methods of determining the health status of an individual
US20090291458A1 (en) * 2008-05-22 2009-11-26 Nodality, Inc. Method for Determining the Status of an Individual
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
WO2010006291A1 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods for diagnosis, prognosis and treatment
USD618820S1 (en) 2008-07-11 2010-06-29 Handylab, Inc. Reagent holder
USD787087S1 (en) 2008-07-14 2017-05-16 Handylab, Inc. Housing
US20100099109A1 (en) * 2008-10-17 2010-04-22 Nodality, Inc., A Delaware Corporation Methods for Analyzing Drug Response
US9034257B2 (en) * 2008-10-27 2015-05-19 Nodality, Inc. High throughput flow cytometry system and method
CN106190806B (en) 2011-04-15 2018-11-06 贝克顿·迪金森公司 Scan real-time microfluid thermal cycler and the method for synchronous thermal cycle and scanning optical detection
USD692162S1 (en) 2011-09-30 2013-10-22 Becton, Dickinson And Company Single piece reagent holder
KR102121853B1 (en) 2011-09-30 2020-06-12 벡톤 디킨슨 앤드 컴퍼니 Unitized reagent strip
CN104040238B (en) 2011-11-04 2017-06-27 汉迪拉布公司 Polynucleotides sample preparation apparatus
CN107881219B (en) 2012-02-03 2021-09-10 贝克顿·迪金森公司 External file for molecular diagnostic test assignment and compatibility determination between tests
US9274071B2 (en) * 2013-12-30 2016-03-01 General Electric Company Methods for assessing cell culture fluid by impedance spectra
CN115151816A (en) * 2019-11-27 2022-10-04 沃特世科技公司 Gradient of gradient proportional valve
WO2023163162A1 (en) * 2022-02-25 2023-08-31 株式会社オンチップ・バイオテクノロジーズ In-droplet particle detection method, method for fractioning/dispensing droplet including particles, method for removing particles to outside from droplet after dispensing, and device therefor

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3826899A (en) 1969-08-15 1974-07-30 Nuclear Res Ass Inc Biological cell analyzing system
US3772154A (en) 1971-05-03 1973-11-13 Technicon Instr Method and apparatus for automated antibiotic susceptibility analysis of bacteria samples
US4343782A (en) 1978-04-20 1982-08-10 Shapiro Howard M Cytological assay procedure
US4271123A (en) 1979-10-22 1981-06-02 Bio-Rad Laboratories, Inc. Automated system for performing fluorescent immunoassays
EP0122772B1 (en) 1983-04-15 1988-08-17 Science and Technology Agency, Minister's Secretariat, Director of Finance Division Chemical manipulator
US4766078A (en) 1985-03-07 1988-08-23 Henry Gang Automated consecutive reaction analyzer
US4676951A (en) 1985-07-01 1987-06-30 American Hospital Supply Corp. Automatic specimen analyzing system
US4678752A (en) 1985-11-18 1987-07-07 Becton, Dickinson And Company Automatic random access analyzer
US5320808A (en) 1988-08-02 1994-06-14 Abbott Laboratories Reaction cartridge and carousel for biological sample analyzer
DE68922390T2 (en) 1988-10-21 1995-10-05 Molecular Devices Corp METHOD AND APPARATUS FOR MEASURING THE EFFECTS OF CELL EFFECTIVE AGENTS ON LIVING CELLS.
US5278048A (en) 1988-10-21 1994-01-11 Molecular Devices Corporation Methods for detecting the effect of cell affecting agents on living cells
US4987084A (en) * 1989-02-21 1991-01-22 Dana Farber Cancer Institute Method of testing the effect of a molecule on B lymphocyte function
FR2654836B1 (en) 1989-11-17 1994-01-28 Biotrol Sa Laboratoires APPARATUS FOR AUTOMATICALLY PERFORMING MULTIPLE SUCCESSIVE IMMUNODAYS OF AT LEAST ONE BIOLOGICAL SUBSTANCE IN A PLURALITY OF BIOLOGICAL SAMPLES, PROCESS AND REAGENT USING THE SAME.
US5326692B1 (en) 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
EP0558671B1 (en) 1990-11-21 1999-01-27 Iterex Pharmaceuticals Ltd. Partnership Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
US5370842A (en) * 1991-11-29 1994-12-06 Canon Kabushiki Kaisha Sample measuring device and sample measuring system
US5670113A (en) * 1991-12-20 1997-09-23 Sibia Neurosciences, Inc. Automated analysis equipment and assay method for detecting cell surface protein and/or cytoplasmic receptor function using same
US5630706A (en) 1992-03-05 1997-05-20 Yang; Frank J. Multichannel pump apparatus with microflow rate capability
US5541061A (en) 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries
WO1994002515A1 (en) 1992-07-21 1994-02-03 Bunsen Rush Laboratories Inc. Oligomer library formats and methods relating thereto
US5585275A (en) 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
NZ283171A (en) * 1994-04-11 1998-02-26 Nexins Research Bv Detecting or quantifying apoptotic cells in a sample
EP0774112B1 (en) * 1994-08-01 2002-07-03 Abbott Laboratories Pseudo telecentric optical design for flow cytometric blood cell analyzer
US5648219A (en) 1995-06-07 1997-07-15 Zymogenetics, Inc. Immortalized dendritic cells
US5463564A (en) 1994-09-16 1995-10-31 3-Dimensional Pharmaceuticals, Inc. System and method of automatically generating chemical compounds with desired properties
EP0817965A1 (en) 1995-03-31 1998-01-14 Novo Nordisk A/S Method for identifying biologically active substances by their effect on living cells
US5633168A (en) * 1995-06-07 1997-05-27 Glasscock; Larry M. Controlled dispersion flow analysis system
US5620894A (en) 1995-06-16 1997-04-15 Glaxo Wellcome Inc. Apparatus for automated biological cell harvesting
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
US5942443A (en) 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
US5804436A (en) * 1996-08-02 1998-09-08 Axiom Biotechnologies, Inc. Apparatus and method for real-time measurement of cellular response
DE19738566C2 (en) * 1997-09-04 1999-07-29 Karlsruhe Forschzent Method and device for identifying active substances
WO1999012041A1 (en) * 1997-09-05 1999-03-11 The Board Of Regents Of The University Of Oklahoma Composition and methods using galectin-1
US6315952B1 (en) * 1998-10-05 2001-11-13 The University Of New Mexico Plug flow cytometry for high throughput screening and drug discovery

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833542B2 (en) 2000-11-13 2004-12-21 Genoptix, Inc. Method for sorting particles
US6815664B2 (en) 2001-04-27 2004-11-09 Genoptix, Inc. Method for separation of particles

Also Published As

Publication number Publication date
US6280967B1 (en) 2001-08-28
JP2003506098A (en) 2003-02-18
EP1204864A2 (en) 2002-05-15
WO2001011333A2 (en) 2001-02-15
AU6893700A (en) 2001-03-05
WO2001011333A3 (en) 2001-08-30
US6242209B1 (en) 2001-06-05

Similar Documents

Publication Publication Date Title
WO2001011333B1 (en) Apparatus for real-time measurement of cellular response
WO1998005959B1 (en) Apparatus and method for real-time measurement of cellular response
US6958221B2 (en) Cell flow apparatus and method for real-time measurements of patient cellular responses
JP3847791B2 (en) Apparatus and method for measuring cellular response in real time
Huebner et al. Quantitative detection of protein expression in single cells using droplet microfluidics
JP2003506098A5 (en)
Sklar et al. Sample handling for kinetics and molecular assembly in flow cytometry
US20060068410A1 (en) Methods and systems for monitoring intracellular binding reactions
CN101021530A (en) Automatic channel resolution chemiluminescent multicomponent immunodetection system and analytical method
Edwards et al. High-throughput flow cytometry for drug discovery
WO2002095355B1 (en) Electrochemical method for high-throughput screening of minute quantities of candidate compounds
US20010036626A1 (en) Screening assay methods and systems using target pooling
US20080081327A1 (en) Method for using division arrested cells in screening assays
EP0574508B1 (en) Method and apparatus for screening microscopic cells utilizing polarized light scatter techniques
Carpenter et al. Configuring radioligand receptor binding assays for HTS using scintillation proximity assay technology
JP6746846B2 (en) Single injection competitive assay
JP2004337152A (en) Method for simultaneously determining cell proliferation inhibitory activity and toxicity
Falkenhain et al. Dead cell estimation—a comparison of different methods
Wu et al. Small‐volume rapid‐mix device for subsecond kinetic analysis in flow cytometry
US20030164294A1 (en) Automated ion analyzer
Dayton et al. Direct determination of endothelin receptor antagonist levels in plasma using a scintillation proximity assay
CN110275011A (en) The sensitization detection method of colloidal gold immunity chromatography and application
Okun et al. Functional characterization of naturally expressed G-protein-coupled receptors in mammalian cells using the automated high-throughput pharmacological system HT-PS 100
Goldman Ilya Okun, Alex Okun, Vellareddy Anantharam, Mark
Djannatian Establishment of a novel technique to study G protein-coupled receptor activation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: B1

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ CZ DE DE DK DK DM DZ EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

B Later publication of amended claims
WWE Wipo information: entry into national phase

Ref document number: 2000957298

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000957298

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000957298

Country of ref document: EP